These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1494808)

  • 21. Adrenocortical Carcinoma: Role of Adjuvant and Neoadjuvant Therapy.
    Kenney L; Hughes M
    Surg Oncol Clin N Am; 2023 Apr; 32(2):279-287. PubMed ID: 36925185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenal cortical carcinoma: the role of adjuvant postoperative chemotherapy.
    Burgess MA
    Minerva Endocrinol; 1995 Mar; 20(1):101-4. PubMed ID: 7651278
    [No Abstract]   [Full Text] [Related]  

  • 23. Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma.
    Jung S; Nagy Z; Fassnacht M; Zambetti G; Weiss M; Reincke M; Igaz P; Beuschlein F; Hantel C
    Endocr Relat Cancer; 2016 Oct; 23(10):825-37. PubMed ID: 27550961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitotane With or Without Cisplatin and Etoposide for Patients with a High Risk of Recurrence in Stages 1-3 Adrenocortical Cancer After Surgery.
    Sarvestani AL; Gregory SN; Teke ME; Terzolo M; Berruti A; Hernandez JM; Habra MA
    Ann Surg Oncol; 2023 Feb; 30(2):680-682. PubMed ID: 36305989
    [No Abstract]   [Full Text] [Related]  

  • 25. 5-Fluorouracil, doxorubicin, and cisplatin as treatment for adrenal cortical carcinoma.
    Schlumberger M; Brugieres L; Gicquel C; Travagli JP; Droz JP; Parmentier C
    Cancer; 1991 Jun; 67(12):2997-3000. PubMed ID: 2044046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study.
    Debets P; Dreijerink KMA; Engelsman A; Dahele M; Haak HR; Steenaard RV; Kapiteijn E; Corssmit E; Menke-van der Houven van Oordt CW
    Eur J Cancer; 2024 Jan; 196():113424. PubMed ID: 37977106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenocortical carcinoma.
    van Ditzhuijsen CI; van de Weijer R; Haak HR
    Neth J Med; 2007 Feb; 65(2):55-60. PubMed ID: 17379929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.
    Wilke H; Preusser P; Fink U; Gunzer U; Meyer HJ; Meyer J; Siewert JR; Achterrath W; Lenaz L; Knipp H
    J Clin Oncol; 1989 Sep; 7(9):1318-26. PubMed ID: 2769330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncocytic adrenocortical carcinoma.
    Tanaka K; Kumano Y; Kanomata N; Takeda M; Hara I; Fujisawa M; Kawabata G; Kamidono S
    Urology; 2004 Aug; 64(2):376-7. PubMed ID: 15302503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Three Cases of Advanced or Recurrent Adrenocortical Carcinoma Patients Treated with Etoposide, Doxorubicin and Cisplatin plus Mitotane].
    Sasaki S
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):67-70. PubMed ID: 29362311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adrenocortical carcinoma and its treatment].
    Tupikowski W; Bednarek-Tupikowska G; Florczak A
    Postepy Hig Med Dosw (Online); 2004 Feb; 58():27-36. PubMed ID: 15069374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic treatment of adrenocortical carcinoma.
    Ahlman H; Khorram-Manesh A; Jansson S; Wängberg B; Nilsson O; Jacobsson CE; Lindstedt S
    World J Surg; 2001 Jul; 25(7):927-33. PubMed ID: 11572034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of gastric adenocarcinoma with the combination of etoposide, adriamycin and cisplatin (EAP): comparison between two schedules.
    Haim N; Tsalik M; Robinson E
    Oncology; 1994; 51(1):102-7. PubMed ID: 8265093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenocortical carcinoma: current treatment options.
    De Filpo G; Mannelli M; Canu L
    Curr Opin Oncol; 2021 Jan; 33(1):16-22. PubMed ID: 33186181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence.
    Calabrese A; Basile V; Puglisi S; Perotti P; Pia A; Saba L; Berchialla P; Porpiglia F; Veltri A; Volante M; Reimondo G; Berruti A; Terzolo M
    Eur J Endocrinol; 2019 Jun; 180(6):387-396. PubMed ID: 30991359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New perspectives for mitotane treatment of adrenocortical carcinoma.
    Puglisi S; Calabrese A; Basile V; Pia A; Reimondo G; Perotti P; Terzolo M
    Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101415. PubMed ID: 32179008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A Case of Adrenocortical Carcinoma Successfully Treated with Multimodal Therapy].
    Bando S; Ishii G; Yamada H; Kimura T; Furuta N; Egawa S
    Hinyokika Kiyo; 2016 Jan; 62(1):15-9. PubMed ID: 26932330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of complete remission in brain metastasis from lung adenocarcinoma with EAP (etoposide, adriamycin, cisplatin)].
    Matsumoto S; Yoshimoto A; Ohsaki A; Murashima N; Ishii Y; Seno N
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1933-6. PubMed ID: 2393312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of Mitotane and Locoregional Treatments in Low-volume Metastatic Adrenocortical Carcinoma.
    Boilève A; Mathy E; Roux C; Faron M; Hadoux J; Tselikas L; Al Ghuzlan A; Hescot S; Leboulleux S; de Baere T; Lamartina L; Deschamps F; Baudin E
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4698-e4707. PubMed ID: 34143888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update in adrenocortical carcinoma.
    Fassnacht M; Kroiss M; Allolio B
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4551-64. PubMed ID: 24081734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.